Update on triple-negative breast cancer: prognosis and management strategies
Triple negative breast cancer (TNBC) is a heterogeneous disease comprehending different orphan breast cancers simply defined by the absence of ER/PR/HER-2. Approximately 15%–20% of all breast cancers belong to this phenotype that has distinct risk factors, distinct molecular features, and a particul...
Main Authors: | Brouckaert, Olivier, Wildiers, Hans, Floris, Giuseppe, Neven, Patrick |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469230/ |
Similar Items
-
Clinical features and prognosis of triple-negative breast cancer
by: Sanz, M Izquierdo, et al.
Published: (2009) -
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
by: Qiu, Jingdan, et al.
Published: (2016) -
Impact of tumor chronology and tumor biology on lymph node metastasis in breast cancer
by: Smeets, Ann, et al.
Published: (2013) -
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
by: Tischkowitz, Marc, et al.
Published: (2007) -
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
by: Tanino, Hirokazu, et al.
Published: (2016)